Skip to Main Content

Bioventus Inc. Class A Common Stock

BVS Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of BVS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
BVS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BVS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BVS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by BVS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

BVS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
BVS Income Statement
BVS Balance Sheet
BVS Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Moldable bone graft compositions Jun. 13, 2023
  • Patent Title: Porous carrier matrix Dec. 20, 2022
  • Patent Title: Method of making osteoinductive bone implant Nov. 08, 2022
  • Patent Title: Systems and methods for improved delivery of osteoinductive molecules in bone repair Sep. 27, 2022
  • Patent Title: Method for producing porous calcium deficient hydroxyapatite granules Jul. 05, 2022
  • Patent Title: Moldable bone graft compositions Nov. 17, 2020
  • Patent Title: Protein delivery with porous metallic structure May. 12, 2020
  • Patent Title: Bioactive grafts and composites Aug. 20, 2019
  • Patent Title: Matrix for enhanced delivery of osteoinductive molecules in bone repair May. 28, 2019
  • Patent Title: Porous calcium deficient hydroxyapatite granules Dec. 11, 2018
  • Patent Title: Method for producing porous calcium deficient hydroxyapatite granules Nov. 20, 2018
  • Patent Title: Systems and methods for improved delivery of osteoinductive molecules in bone repair Nov. 20, 2018
  • Patent Title: Moldable bone graft compositions Jul. 31, 2018
  • Patent Title: Moldable bone graft compositions Feb. 14, 2017
Government Contracts

Estimated quarterly amount awarded from public contracts

BVS News

Recent insights relating to BVS

WallStreetBets

Number of mentions of BVS in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for BVS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BVS

BVS Analyst Ratings

BVS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
BVS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $BVS stock a Buy, Sell, or Hold?

  • What is the price target for $BVS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

BVS Top Shareholders
Shareholder
Shares Held
BVS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $BVS stock?

  • Who owns the most shares of $BVS stock?

  • What funds own $BVS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

BVS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BVS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top